# FDA Inspection 1298296 - Mitsubishi Tanabe Pharma Development America, Inc. - September 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/966fdd86-5f4d-4564-b692-4041fbe72ffd
Source feed: FDA_Inspections

> FDA Inspection 1298296 for Mitsubishi Tanabe Pharma Development America, Inc. on September 18, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298296
- Company Name: Mitsubishi Tanabe Pharma Development America, Inc.
- Inspection Date: 2025-09-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1298296 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/dceb2a25-e1ea-4e5b-a250-2f0f9fccf476)
- [FDA Inspection 1155136 - 2021-10-15](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/f7044b8b-5d0a-4038-b5b4-93419bd38f76)
- [FDA Inspection 857641 - 2013-12-04](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-development-america-inc/24eb30a9-ccc6-44e7-bcfa-9e1a8da6556c)

Company: https://www.keypedia.com/companies/mitsubishi-tanabe-pharma-development-america-inc/f5e77e46-b625-4cdd-a44a-ecd7583b6baa